论文部分内容阅读
目的观察阿莫西林克拉维酸钾对小儿肺炎的治疗效果。方法将100例小儿肺炎患者随机分为观察组和对照组各50例。观察组患儿予以阿莫西林克拉维酸钾治疗,对照组患儿予以哌拉西林治疗,对比2组患儿临床治疗效果、症状体征消失时间及治疗时间。结果治疗组治疗总有效率为92%高于对照组的56%,差异有统计学意义(P<0.05)。观察组患儿的疗程时间、肺部音消失时间、退热时间、扁桃体及咽部充血消失时间以及咳嗽消失时间均短于对照组,差异均有统计学意义(P<0.05)。结论应用阿莫西林克拉维酸钾对小儿肺炎患儿进行治疗具有良好的临床治疗效果,并且不良反应发生率低,安全可靠。
Objective To observe the therapeutic effect of amoxicillin and clavulanate potassium on pediatric pneumonia. Methods 100 cases of children with pneumonia were randomly divided into observation group and control group of 50 cases. Children in the observation group were treated with amoxicillin and clavulanate potassium, while those in the control group were given piperacillin. The clinical effects, the disappearance of symptoms and signs, and the duration of treatment were compared between the two groups. Results The total effective rate of treatment group was 92% higher than 56% of control group, the difference was statistically significant (P <0.05). The duration of treatment, disappearance of lung sound, antipyretic time, disappearance of tonsil and pharynx congestion and disappearance of cough in observation group were shorter than those in control group (P <0.05). Conclusion The application of amoxicillin and clavulanate potassium in children with pneumonia has a good clinical therapeutic effect, and the incidence of adverse reactions is low, safe and reliable.